Tryptamine

Tryptamine at a Glance

Tryptamine is the structural parent of the entire tryptamine (indolealkylamine) family — an indole ring joined to a short ethylamine chain. It is the direct decarboxylation product of the amino acid tryptophan, and it is the biosynthetic scaffold from which the body and plants build a long list of famous molecules: serotonin, melatonin, the N-methylated psychedelics N,N-DMT and 5-MeO-DMT, the harmala β-carbolines, and — in plants — the growth hormone auxin ^{1,6,10Reference 1Bunzow JR et al. · 2001AnimalAmphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptorView study →Reference 6Mano Y · 2012The pathway of auxin biosynthesis in plantsView study →Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}.

In its own right tryptamine is an endogenous trace amine: a monoamine that circulates and signals at very low concentrations, acting as a neuromodulator rather than a bulk neurotransmitter ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. Its best-defined molecular target is trace amine-associated receptor 1 (TAAR1), the receptor family for which it is a founding endogenous agonist ^{4,5Reference 4Borowsky B et al. · 2001Trace amines: identification of a family of mammalian G protein-coupled receptorsView study →Reference 5Lindemann L · 2005A renaissance in trace amines inspired by a novel GPCR familyView study →}. It also has documented roles at the gut–microbiome interface and a classic monoamine vascular (pressor) profile ^{8,9Reference 8Bhattarai Y et al. · 2018Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic SecretionView study →Reference 9Broadley KJ et al. · 2013AnimalFunctional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetaminesView study →}.

The single most important fact about the molecule is what it is not: tryptamine is not a psychedelic. It is oxidatively deaminated by monoamine oxidase (MAO) within seconds, so it never reaches meaningful brain levels after oral intake — the reason it is inert by mouth on its own, and the reason its psychoactive relatives need either injection or a β-carboline MAO inhibitor to work orally ^{3,11Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →Reference 11Storch A et al. · 2006Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cellsView study →}.

Root of the Tryptamine Family Tree

This is the point of the page. Almost every molecule in this batch — and several of the most important signalling molecules in biology — is a decorated tryptamine. The scaffold is assembled in one step: aromatic L-amino acid decarboxylase (AADC/DDC in animals, tryptophan decarboxylase, TDC, in plants) strips the carboxyl group from L-tryptophan to give tryptamine ^{6,10Reference 6Mano Y · 2012The pathway of auxin biosynthesis in plantsView study →Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}. From that core, four kinds of chemistry generate the rest of the family:

N-methylation adds methyl groups to the side-chain nitrogen: tryptamine → N-methyltryptamine → N,N-DMT; ring-hydroxylated versions give 5-MeO-DMT and bufotenin. These N,N-dimethylated tryptamines are the class’s serotonergic psychedelics.
Ring hydroxylation at the 5-position gives serotonin (5-hydroxytryptamine) and, downstream, melatonin and N-methylserotonin. In plants this genuinely proceeds through tryptamine (TDC → tryptamine → serotonin); in mammals the main serotonin route instead runs via 5-hydroxytryptophan, so tryptamine is better described as the class’s structural parent than as the mammalian precursor of serotonin ^{10Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}.
Pictet–Spengler condensation with an aldehyde folds the ethylamine chain back onto the indole to make a new ring — a tetrahydro-β-carboline. Condense tryptamine with acetaldehyde and you get the tetrahydro-β-carboline skeleton of tetrahydroharman; oxidation and methoxylation give the fully aromatic harmala alkaloids harmine, harmaline, harman, harmalol and tetrahydroharmine ^{11Reference 11Storch A et al. · 2006Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cellsView study →}. This single reaction is why tryptamines and β-carbolines co-occur throughout the batch’s source plants.
Oxidative side-chain conversion in plants turns tryptamine into indole-3-acetaldehyde and then indole-3-acetic acid (IAA) — the principal auxin, the hormone that governs plant growth and tropisms ^{6Reference 6Mano Y · 2012The pathway of auxin biosynthesis in plantsView study →}.

Read the rest of this batch through that lens: the β-carbolines are tryptamine cyclised onto an aldehyde, the DMTs are tryptamine methylated, and serotonin is tryptamine hydroxylated.

What It's Used For

Tryptamine has no therapeutic application — it is studied as an endogenous signalling molecule, not a drug. The evidence is mechanistic and preclinical, and it clusters around three physiological roles: trace-amine neuromodulation, gut–microbiome signalling, and monoamine vascular activity.

A genuine endogenous trace amine.Tryptamine occurs natively in the mammalian brain and periphery at low-nanomolar levels, turns over extremely fast, and behaves as a neuromodulator of classical monoamine (dopamine/serotonin) systems rather than a transmitter in its own pool ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}.

A founding TAAR1 agonist.Its clearest molecular target is trace amine-associated receptor 1, the Gs-coupled receptor family identified for exactly these amines; recombinant TAAR1 responds to tryptamine with increased cAMP ^{4,5Reference 4Borowsky B et al. · 2001Trace amines: identification of a family of mammalian G protein-coupled receptorsView study →Reference 5Lindemann L · 2005A renaissance in trace amines inspired by a novel GPCR familyView study →}.

A gut–microbiome signal.Human gut bacteria carry dedicated decarboxylases that convert dietary tryptophan into tryptamine, which then acts on the colonic epithelium (via a 5-HT4 receptor) to speed secretion and transit — a concrete host–microbe signalling role ^{7,8Reference 7Williams BB et al. · 2014Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamineView study →Reference 8Bhattarai Y et al. · 2018Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic SecretionView study →}.

The honest headline.It is not psychoactive on its own — MAO deaminates it within seconds, so oral tryptamine never reaches the brain intact; and there are essentially no human efficacy trials of the isolate, because it is a metabolite, not a medicine ^{3,11Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →Reference 11Storch A et al. · 2006Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cellsView study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. These are physiological-role scores for an endogenous molecule, not clinical-efficacy scores; there is no therapeutic use to rank.

Mechanisms

Target / pathway	Effect	Relevant to
Aromatic L-amino acid decarboxylase (AADC/DDC; plant TDC)	forms tryptamine by decarboxylating L-tryptophan	biosynthesis (upstream)
Trace amine-associated receptor 1 (TAAR1)	agonist → Gs-coupled ↑ cAMP; modulates dopamine/serotonin transmission	trace-amine neuromodulation
5-HT4 receptor (colonic epithelium)	agonist → ↑ colonic anion/fluid secretion, faster GI transit	gut–microbiome signalling
Monoamine transporters / indirect release	weak amphetamine-like interaction contributing to indirect sympathomimetic (pressor) tone	vascular / pressor
Monoamine oxidase (MAO-A and MAO-B)	rapid oxidative deamination → indole-3-acetaldehyde → indole-3-acetic acid (excreted)	pharmacokinetics / inactivation

The load-bearing rows are the first and last: tryptamine is made by decarboxylating tryptophan and destroyed by MAO, and that fast MAO turnover is the whole reason it is a trace amine and not a psychoactive drug.

Pharmacokinetics

Tryptamine’s pharmacokinetics are dominated by one fact: it is an excellent monoamine oxidase substrate, oxidatively deaminated by both MAO-A and MAO-B to indole-3-acetaldehyde and onward to indole-3-acetic acid, which is excreted ^{3Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. As a result its biological half-life is on the order of seconds, and steady-state tissue concentrations sit in the low-nanomolar range — hence “trace” amine ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. Two consequences define the molecule:

Orally it is inactivated by first-pass MAO in the gut wall and liver before it can reach the systemic circulation or brain, so ingested tryptamine is not psychoactive on its own ^{3,11Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →Reference 11Storch A et al. · 2006Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cellsView study →}.
It does not accumulate. Even where it is produced in quantity (the gut lumen, fermented foods), MAO clears it rapidly unless that enzyme is blocked.

Robust human ADME parameters (Cmax, oral bioavailability of the isolate) are not meaningfully defined, because tryptamine is handled as an endogenous metabolite rather than dosed as a drug ^{3Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}.

Clinical Trials

There are no controlled clinical trials of isolated tryptamine as a therapeutic. It appears in human research only as an endogenous or dietary analyte (urinary/plasma trace-amine measurements) and as the chemical parent of compounds — the psychedelics and the β-carbolines — that are themselves in trials.

Completed	Planned	Terminated	Preclinical
—(endogenous/dietary analyte only)	—	—	Trace-amine/TAAR1, gut-signalling and vascular mechanistic work ^{4,8,9Reference 4Borowsky B et al. · 2001Trace amines: identification of a family of mammalian G protein-coupled receptorsView study →Reference 8Bhattarai Y et al. · 2018Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic SecretionView study →Reference 9Broadley KJ et al. · 2013AnimalFunctional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetaminesView study →}

Last checked: July 2026.

Not a Psychedelic — Why Tryptamine Itself Is Inactive

Because tryptamine is the scaffold of DMT and psilocybin, it is often assumed to be psychoactive. It is not, and the reasons are instructive.

First, it lacks the decorations. The psychedelic tryptamines carry specific substitutions — the two N-methyl groups of N,N-DMT, the 4-phosphoryloxy of psilocybin, the 5-methoxy of 5-MeO-DMT — that give strong 5-HT2A receptor agonism. Bare tryptamine is a weak, non-selective ligand by comparison; its defining native target is TAAR1, not the 5-HT2A receptor that mediates classical psychedelic effects ^{5Reference 5Lindemann L · 2005A renaissance in trace amines inspired by a novel GPCR familyView study →}.

Second, and decisively, MAO destroys it. Tryptamine is deaminated within seconds ^{3Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. This is the same barrier that makes even N,N-DMT orally inactive — and it is the reason the harmala β-carbolines exist as the other half of this batch. Ayahuasca works orally only because β-carboline MAO inhibitors such as harmine and harmaline block the enzyme long enough for orally ingested DMT to survive. Tryptamine sits at the centre of that story twice over: it is the amine those β-carbolines are built from (via Pictet–Spengler condensation), and it is a substrate of the very enzyme they inhibit.

The takeaway is a clean piece of structure–activity logic: potency at 5-HT2A plus resistance to MAO is what separates a psychedelic from a trace amine — and tryptamine has neither.

Its Role in Plants

In plants, tryptamine is a metabolic crossroads rather than an end-product. Tryptophan decarboxylase (TDC) makes it from tryptophan, and from there it feeds two important routes ^{6,10Reference 6Mano Y · 2012The pathway of auxin biosynthesis in plantsView study →Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}:

Auxin (IAA) Biosynthesis

The tryptamine (TAM) pathway is one of the classic tryptophan-dependent routes to indole-3-acetic acid (IAA) — the principal auxin, the hormone controlling cell elongation, apical dominance, root initiation and tropic bending. Tryptamine is oxidised to indole-3-acetaldehyde and then to IAA; this pathway is one of four Trp-dependent routes plants use to make auxin ^{6Reference 6Mano Y · 2012The pathway of auxin biosynthesis in plantsView study →}.

Serotonin & Melatonin

Plants also convert tryptamine to serotonin (by 5-hydroxylation) and onward to melatonin, and these indoleamines act in plant stress tolerance, senescence and defence ^{10Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}. Notably, the plant route to serotonin runs through tryptamine — unlike the dominant mammalian route — which is why tryptamine is a more central precursor in botany than in animal physiology ^{10Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}.

These are plant-biology functions and should not be read as human pharmacology.

Prevalence in Nature

Tryptamine is taxonomically widespread but almost always a minor constituent, because it is a rapidly-turned-over intermediate rather than a storage product. In plants it is reported across many families — famously in Acacia species and in grasses such as Phalaris (where tryptamine and its N-methyl/DMT derivatives underlie livestock “phalaris staggers”), as well as legumes and numerous others — usually alongside its methylated and cyclised derivatives ^{10Reference 10Negri S et al. · 2021The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metaboliteView study →}. As the free amine it is typically present at low concentrations; the more abundant, storable members of its family (serotonin, the β-carbolines, the DMTs) are the ones that accumulate.

It is also endogenous in animals, present natively in the mammalian brain and periphery as a trace amine ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}, and it is produced in the human gut by microbial tryptophan decarboxylases ^{7Reference 7Williams BB et al. · 2014Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamineView study →}. Finally, tryptamine forms in fermented and aged foods — cheeses, cured/fermented sausages and other protein-rich fermented products — where microbial decarboxylation of tryptophan generates it as one of several biogenic amines ^{12Reference 12Gardini F et al. · 2016ReviewTechnological Factors Affecting Biogenic Amine Content in Foods: A ReviewView study →}.

No clean, comparable per-source concentration figures were available for a “Content by Source” chart; the holes are logged in this molecule’s gaps tracker.

Discovery & Synthesis

Tryptamine was recognised early in the twentieth century as the decarboxylation product of tryptophan, and its name records that parentage directly — tryptophan + amine. Its enduring scientific interest, however, dates to the 1970s–80s, when work on the mammalian brain established that tryptamine is not merely a metabolic curiosity but a genuine endogenous trace amine / neuromodulator, present natively and turning over rapidly ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. The molecular vindication came in 2001, when the trace amine-associated receptors (TAARs) were cloned and tryptamine was shown to be one of their endogenous agonists — reframing the trace amines as a signalling system with their own receptor family ^{4,5Reference 4Borowsky B et al. · 2001Trace amines: identification of a family of mammalian G protein-coupled receptorsView study →Reference 5Lindemann L · 2005A renaissance in trace amines inspired by a novel GPCR familyView study →}.

Manufacture today is straightforward synthetic organic chemistry: tryptamine is a cheap, commercially available fine chemical (made by decarboxylation of tryptophan or by total synthesis) used mainly as a laboratory reference standard and a chemical building block, including as the starting material for synthesising its substituted relatives. It is not extracted from plants at scale — there is no commercial reason to, given how easily it is synthesised.

Patents: not yet researched.

Toxicity & Safety

Tryptamine carries a low intrinsic-toxicity flag. It is an endogenous molecule present in normal human metabolism, it does not accumulate (MAO clears it within seconds), and on its own it is not psychoactive and not orally active ^{3Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. There is no toxic syndrome associated with ordinary endogenous or dietary tryptamine.

The one caution that matters is conditional, not intrinsic: like the related dietary amine tyramine, tryptamine has a sympathomimetic/pressor action ^{9Reference 9Broadley KJ et al. · 2013AnimalFunctional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetaminesView study →}, and its rapid MAO clearance is the safety valve that keeps that action invisible at normal exposures. If MAO is inhibited — by an MAOI antidepressant, or by the batch’s own β-carbolines (harmine, harmaline) — that clearance is removed, and dietary/endogenous tryptamine (and its relatives) can build up and drive a hypertensive/“tyramine-type” pressor response. This is a drug/diet interaction, not a property of the molecule in isolation.

Safety at a Glance

Low / no toxicity

Endogenous and non-accumulating. A native trace amine cleared within seconds by MAO; not psychoactive and not orally active on its own ^{2,3Reference 2Berry MD · 2004Mammalian central nervous system trace aminesView study →Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}.
No toxicity syndrome at ordinary exposure. Normal dietary and endogenous levels are far too low to cause harm.
MAO-inhibitor interaction (pressor). With an MAOI or β-carboline MAOI on board, tryptamine’s sympathomimetic action is unmasked, contributing to a tyramine-type hypertensive response ^{9Reference 9Broadley KJ et al. · 2013AnimalFunctional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetaminesView study →}.
Fermented/aged foods raise dietary load. Cheeses and fermented meats carry tryptamine among their biogenic amines — relevant mainly to people on MAO inhibitors ^{12Reference 12Gardini F et al. · 2016ReviewTechnological Factors Affecting Biogenic Amine Content in Foods: A ReviewView study →}.

Pregnancy/lactation is a per-herb / per-supplement decision and is not adjudicated on this molecule page; tryptamine is an endogenous metabolite, and no isolate-specific reproductive verdict is issued here.

Dosage

There is no human therapeutic dose for tryptamine. It is an endogenous trace amine and metabolic intermediate, not a supplement or medicine, and it is not taken deliberately — oral tryptamine is destroyed by first-pass MAO before it can act ^{3Reference 3Gainetdinov RR et al. · 2018Trace Amines and Their ReceptorsView study →}. The only “amounts” in the literature are endogenous tissue/plasma concentrations (low-nanomolar) and in-vitro or animal research values, none of which translate to human self-dosing. These are research and physiological figures, not a personal recommendation.

References

Bunzow JR, et al. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Molecular Pharmacology. https://pubmed.ncbi.nlm.nih.gov/11723224/
Berry MD (2004). Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. Journal of Neurochemistry. https://pubmed.ncbi.nlm.nih.gov/15228583/
Gainetdinov RR, Hoener MC, Berry MD (2018). Trace Amines and Their Receptors. Pharmacological Reviews. https://pubmed.ncbi.nlm.nih.gov/29941461/
Borowsky B, et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proceedings of the National Academy of Sciences USA. https://pubmed.ncbi.nlm.nih.gov/11459929/
Lindemann L, Hoener MC (2005). A renaissance in trace amines inspired by a novel GPCR family. Trends in Pharmacological Sciences. https://pubmed.ncbi.nlm.nih.gov/15860375/
Mano Y, Nemoto K (2012). The pathway of auxin biosynthesis in plants. Journal of Experimental Botany. https://pubmed.ncbi.nlm.nih.gov/22447967/
Williams BB, et al. (2014). Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host & Microbe. https://pubmed.ncbi.nlm.nih.gov/25263219/
Bhattarai Y, et al. (2018). Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. Cell Host & Microbe. https://pubmed.ncbi.nlm.nih.gov/29902441/
Broadley KJ, et al. (2013). Functional evaluation of the receptors mediating vasoconstriction of rat aorta by trace amines and amphetamines. European Journal of Pharmacology. https://pubmed.ncbi.nlm.nih.gov/23665489/
Negri S, et al. (2021). The case of tryptamine and serotonin in plants: a mysterious precursor for an illustrious metabolite. Journal of Experimental Botany. https://pubmed.ncbi.nlm.nih.gov/34009335/
Storch A, et al. (2006). Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells. Journal of Neural Transmission. https://pubmed.ncbi.nlm.nih.gov/16868795/
Gardini F, et al. (2016). Technological Factors Affecting Biogenic Amine Content in Foods: A Review. Frontiers in Microbiology. https://pubmed.ncbi.nlm.nih.gov/27570519/